AMZN
Amazon.com, Inc.
AMZN has the edge over HNST overall, supported by lower modeled downside and stronger valuation.
HNST
The Honest Company, Inc.
HNST's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HNST Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Strong | |
| Strong |
HNST's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
HNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7x | $4.80 | — |
| Cheap | 41x | $28.21 | +488% |
| Fair | 45x | $31.17 | +549% |
| Forward | 60x | $4.80 | — |
| Expensive | 78x | $53.97 | +1024% |
Historical ranges are pointers, not guarantees.
HNST has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over HNST on the outlook, with more favorable revenue expectations.
HNST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect HNST's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HNST on earnings, with more consistent year-over-year improvement.
HNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.08 | -88% |
| Q3 2026 | $0.69 | +1050% |
| Q2 2026 | -$0.11 | -320% |
| Q1 2026 | -$0.17 | -$0.15 |
| Q4 2025 | -$0.14 | -$0.08 |
| Q3 2025 | $0.06 | +$0.10 |
| Q2 2025 | $0.05 | +$0.18 |
| Q1 2025 | -$0.02 | +$0.21 |
| Q4 2024 | -$0.06 | +$0.36 |
HNST's earnings per share have jumped to their highest in six years: $0.69 over the past year, up from $0.06 the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over HNST on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over HNST on profitability, with a higher operating margin.
HNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.6M | -8.6% |
| Q2 2026 | $83.3M | -11% |
| Q1 2026 | $78.1M | -20% |
| Q4 2025 | $88M | -12% |
| Q3 2025 | $92.6M | -6.7% |
| Q2 2025 | $93.5M | +0.4% |
| Q1 2025 | $97.3M | +13% |
| Q4 2024 | $99.8M | +11% |
HNST's revenue has slid since its 2024 peak: $85M last quarter, down 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | +1 points |
| Q2 2026 | 12% | +8.4 points |
| Q1 2026 | -0.8% | -3.4 points |
| Q4 2025 | -27% | -26 points |
| Q3 2025 | 0.3% | +0.3 points |
| Q2 2025 | 3.1% | +7.4 points |
| Q1 2025 | 2.6% | +4.1 points |
| Q4 2024 | -1% | -2.3 points |
HNST's operating margin was 1.4% last quarter, up 1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.8M | -$4.1M |
| Q2 2026 | $31.5M | +$32.3M |
| Q1 2026 | $3.8M | +$6.8M |
| Q4 2025 | $18.1M | +$35.2M |
| Q3 2025 | -$624K | -104% |
| Q2 2025 | -$826K | -128% |
| Q1 2025 | -$3M | -1254% |
| Q4 2024 | -$17.2M | -278% |
HNST has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HNST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -627K shares |
| 1 year | -1.1% | -1.2M shares |
| 3 years | +18% | +17.3M shares |
| 5 years | +65% | +44.4M shares |
| Available history | +29% | +25.3M shares |
HNST has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.1M |
| Q2 2026 | $16.1M |
| Q1 2026 | $3M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -9.4x | Net Cash |
| Q2 2025 | -9.9x | Net Cash |
| Q1 2025 | -218.7x | Net Cash |
HNST has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 34.6 | Neutral |
HNST's weekly RSI is 54 (neutral) and its Stochastic is 35 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
HNST PE vs Consumer Cyclical Sector
| Metric | HNST | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 18x | 61% below |
| PE % | 3 | 53 | 50 pts below |
HNST has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over HNST on trend strength, trading above more of its moving averages.
HNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.87 | 1.4% below |
| 20 week MA | $4.79 | 0.2% above |
| 50 week MA | $3.69 | 30% above |
| 100 week MA | $4.19 | 15% above |
| 200 week MA | $3.54 | 36% above |
HNST's trend is up, with a small recent dip: it's below only its 8-week average, and 36% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
HNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.1 | $8.07 | -58% |
| 2022 | $8.07 | $2.97 | -63% |
| 2023 | $2.97 | $3.30 | +11% |
| 2024 | $3.30 | $6.93 | +110% |
| 2025 | $6.93 | $2.71 | -61% |
| 2026 YTD | $2.71 | $4.80 | +77% |
HNST has the edge over AMZN on returns for 2026, with the stronger performance.